| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |